Interactive Brokers Advertisement
Home > Boards > Canadian > Cannabis > Aphria Inc (TSX:APH)

Aphria (TSX:APH)......

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Hunchbackgeek Member Profile
Member Level 
Followed By 525
Posts 18,760
Boards Moderated 25
Alias Born 03/16/14
160x600 placeholder
The Therapeutic Potential of Pharmacologically Active Cannabinoids "NetworkNewsWire" - 12/12/2017 8:45:00 AM
S&P Dow Jones Indices annonce des modifications aux indices canadiens S&P/TSX "PR Newswire (Canada)" - 12/8/2017 8:08:00 PM
S&P Dow Jones Indices Announces Changes to the S&P/TSX Canadian Indices "PR Newswire (Canada)" - 12/8/2017 5:15:00 PM
Purified Cannabinoids Open New Opportunities in Pain Management "NetworkNewsWire" - 12/5/2017 8:45:00 AM
L'OCRCVM permet la reprise de la négociation - APH "PR Newswire (Canada)" - 12/4/2017 4:09:00 PM
IIROC Trade Resumption - APH "PR Newswire (Canada)" - 12/4/2017 4:07:00 PM
Suspension de la négociation par l'OCRCVM - APH "PR Newswire (Canada)" - 12/4/2017 4:03:00 PM
IIROC Trading Halt - APH "PR Newswire (Canada)" - 12/4/2017 4:01:00 PM
Aphria enters into supplier agreement with Shoppers Drug Mart "PR Newswire (Canada)" - 12/4/2017 3:57:00 PM
Investors Could Reap Global Rewards of Research into Medical Cannabis Science "NetworkNewsWire" - 11/30/2017 8:45:00 AM
Aphria Achieves Next Milestone in International Expansion Strategy with Receipt of Dealer's License "PR Newswire (Canada)" - 11/23/2017 8:00:00 AM
Coming Cannabis Recreational Demand in Canada Triggers Massive Investment "NetworkNewsWire" - 11/20/2017 8:45:00 AM
Biosynthesis: Making the Impossible Possible in Medicinal Cannabis "NetworkNewsWire" - 11/14/2017 8:45:00 AM
Aphria Announces Closing of Bought Deal Financing "PR Newswire (Canada)" - 11/7/2017 10:04:00 AM
Leaders in Medical Marijuana and the Global Alzheimer’s Markets "NetworkNewsWire" - 10/31/2017 8:45:00 AM
Shareholders elect Renah Persofsky and Shawn Dym to Aphria's Board of Directors "PR Newswire (Canada)" - 10/27/2017 8:00:00 AM
Biotechs Develop Proprietary Systems to Drive CBD Research and Development "NetworkNewsWire" - 10/25/2017 8:45:00 AM
Aphria Completes First Medical Cannabis Oil (CBD/THC) Shipment to Australia-based Medlab "PR Newswire (Canada)" - 10/24/2017 7:30:00 AM
Aphria engages in positive dialogue with Toronto Stock Exchange "PR Newswire (Canada)" - 10/23/2017 7:00:00 AM
Aphria welcomes new CSA disclosure guidelines, provides comment on TSX staff notice "PR Newswire (Canada)" - 10/17/2017 7:15:00 AM
Aphria reports strong performance in Q1 2018, including record revenue and grams sold "PR Newswire (Canada)" - 10/13/2017 8:00:00 AM
New Proposed Federal Tax Plan for Cannabis Underscores Need for Low Cost Producers "PR Newswire (Canada)" - 10/5/2017 8:00:00 AM
Demand Outpacing Supply as Canadian Cannabis Legalization Looms "NetworkNewsWire" - 10/3/2017 8:45:00 AM
Production Bottleneck Spells Opportunity for Canada’s Cannabis Producers "NetworkNewsWire" - 9/21/2017 8:45:00 AM
Namaste Announces Product Acquisition Agreement With Aphria Inc. "InvestorsHub NewsWire" - 9/20/2017 10:31:49 AM
Hunchbackgeek Member Level  Monday, 07/10/17 01:23:24 PM
Re: Goodbuddy4863 post# 695
Post # of 806 
Aphria (TSX:APH)......
Also licensed under the ACMPR, much like other companies on the Canadian marijuana stocks, Aphria is located in Learnington, Ontario.

The company self-describes itself as “truly powered by sunlight”, which they state allows for natural growing conditions to produce safe medical cannabis products.

Last June, the company announced it expects to more than double its growing capacity—the company’s board approved in September a $24.5 million project increasing its greenhouse square footage from 100,000 to 300,000 square feet, expected to be completed later this year. The company expects that the expansion will be able to bump growing capabilities from 5,500 kilograms to 18,000 kilograms annually.

Aphria is also in the midst of completing its previously disclosed 57,000 square foot Part II expansion, is on target for full crop rotation by June 2017. In early February, the company announced that it moved from the TSX Venture Exchange to the TSX Exchange. A week later, Aphria announced a $50 million bought deal financing.

Putting it simply, 2017 has also been a busy year for Aphria, and with the legalization date set for recreational use, that isn’t about to stop. In April, the company announced it had secured a $100 million raise–$75 million of which will be used for a bought deal equity financing, with the remainder a debt financing through a five-year term loan.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist